Unknown

Dataset Information

0

Cytoreductive Nephrectomy in 2021: Obsolete.

ABSTRACT:

SUBMITTER: Meza L 

PROVIDER: S-EPMC8724935 | biostudies-literature | 2022 Feb

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Cytoreductive Nephrectomy in 2021: Obsolete.

Meza Luis L   Chawla Neal S NS   Giannarini Gianluca G   Pal Sumanta K SK  

European urology open science 20211229

Similar Datasets

Unknown Cytoreductive Nephrectomy in 2021: Obsolete but Necessary.
| S-EPMC8724938 | biostudies-literature
Unknown New Paradigms for Cytoreductive Nephrectomy.
| S-EPMC9179532 | biostudies-literature
Unknown Lymph node dissection during cytoreductive nephrectomy: a retrospective analysis.
| S-EPMC4146659 | biostudies-literature
Unknown Comprehensive characterization of the perioperative morbidity of cytoreductive nephrectomy.
| S-EPMC4893515 | biostudies-literature
Unknown Current role of cytoreductive nephrectomy in metastatic renal cell carcinoma.
| S-EPMC8057358 | biostudies-literature
Unknown A qualitative framework of non-selection factors for cytoreductive nephrectomy.
| S-EPMC8478968 | biostudies-literature
Unknown The current role of cytoreductive nephrectomy for metastatic renal cell carcinoma.
| S-EPMC8033221 | biostudies-literature
Unknown "PROBE"ing the Role of Cytoreductive Nephrectomy in Advanced Renal Cancer.
| S-EPMC8929722 | biostudies-literature
Unknown The Evolving Landscape of Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma.
| S-EPMC10417043 | biostudies-literature
Unknown Complications associated with perioperative use of tyrosine kinase inhibitor in cytoreductive nephrectomy.
| S-EPMC6813342 | biostudies-literature